Baicalin improves antioxidant status of streptozotocin-induced diabetic wistar rats

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 10, 2009, Pages 4096-4102

  Waisundara, Viduranga Y ^a   Hsu, Annie ^b   Tan, Benny Kwong Huat ^b   Huang, Dejian ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Baicalin; Diabetes; Metformin; Oxidative stress; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; ANTIOXIDANT; BAICALIN; CATALASE; FLAVONOID; GLUTATHIONE PEROXIDASE; INSULIN; LIPID; METFORMIN; SUPEROXIDE DISMUTASE;

ANIMAL; ARTICLE; BLOOD; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; LIVER; MALE; METABOLISM; OXIDATIVE STRESS; RAT; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CATALASE; DIABETES MELLITUS, EXPERIMENTAL; FLAVONOIDS; GLUTATHIONE PEROXIDASE; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; LIVER; MALE; METFORMIN; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

RATTUS; RATTUS NORVEGICUS;

EID: 66149113917     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf8028539     Document Type: Article

References (30)

1. Forbes, J. M.; Coughlan, M. T.; Cooper, M. E. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes 2008, 57, 1446-1454.
2. Rhodes, C. Type II diabetes: a matter of β-cell life or death?. Science 2005, 307, 380-384.
3. Hovind, P.; Tarnow, L.; Rossing, K.; Rossing, P.; Eising, S.; Larsen, N.; Binder, C.; Parving, H. H. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 2003, 26, 1258-1264.
4. Rother, K. I. Diabetes treatment - bridging the divide. N. Engl. J. Med. 2007, 356, 1499-1501.
5. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature (London) 2001, 414, 813-820.
6. Brownlee, M. The pathobiology of diabetes: a unified mechanism (Banting lecture). Diabetes 2005, 54, 1615-1625.
7. Evans, J. L.; Maddux, B. A.; Goldfine, I. D. Antioxidants in diabetic complications and insulin resistance. In Diabetes: From Research to Diagnosis and Treatment; Raz, A., Ed.; Martin Dunitz: London, U.K., 2003; pp 479-496.
8. Coppey, L. J.; Gellett, J. S.; Davidson, E. P.; Dunlap, J. A.; Lund, D. D.; Yorek, M. A. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 2001, 50, 1927-1937.
9. Dierckx, N.; Horvath, G.; van Gils, C.; Vertommen, J.; van de Vliet, J.; De Leeuw, I.; Manuel-y-Keenoy, B. Oxidative stress status in patients with diabetes mellitus: relationship to diet. Eur. J. Clin. Nutr 2003, 57, 999-1008.
10. Du, X.; Edelstein, D.; Brownlee, M. Oral benfotiamine plus α-lipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia 2008, 1-3.
11. Skibola, C. F.; Smith, M. T. Potential health impacts of excessive flavonoid intake. Free Radical Biol. Med. 2000, 29, 375-383.
12. Ou, B. X.; Huang, D. J.; Hampsch-Woodill, M.; Flanagan, J. When East meets West: the relationship between yin-yang and antioxidation-oxidation. FASEB J. 2003, 17, 127-129.
13. Schinella, G. R.; Tournier, H. A.; Prieto, J. M.; Mordujovich , P.; Rios, J. L. Antioxidant activity of anti-inflammatory plant extracts. Life Sci 2002, 70, 1023-1033.
14. Ho, J. H.; Kim, D. O.; Soo, J. C.; Dong, H. S.; Chang, Y. L. Potent inhibitory effect of flavonoids from Scutellaria baicalensis on amyloid β protein-induced neurotoxicity. J. Agric. Food Chem. 2004, 54, 4128-4132.
15. Waisundara, V. Y.; Hsu, A.; Huang, D. J.; Tan, B. K. H. Scutellaria baicalensis enhances the anti-diabetic activity of metformin in streptozotocin-induced diabetic Wistar rats. Am. J. Chinese Med. 2008, 36, 517-540.
16. Cheng, J. T.; Huang, C. C.; Liu, I. M.; Tzeng, T. F.; Chang, C. J. Novel mechanism for plasma glucose-lowering action for metformin in streptozotocin-induced diabetic rats. Diabetes 2006, 55, 819-825.
17. Huang, D. J.; Ou, B. X.; Hampsch-Woodill, M.; Flanagan, J. A.; Prior, R. L. High-throughput assay of oxygen radical absorbance capacity (ORAC) using a multichannel liquid handling system coupled with a microplate fluorescence reader in 96-well format. J. Agric. Food Chem. 2002, 50, 4437-4444.
18. Hay, K. X.; Waisundara, V. Y.; Yong, Z.; Han, M. Y.; Huang, D. J. CdSe nanocrystals as hydroperoxide scavengers: a new approach to highly sensitive quantification of lipid hydroperoxides. Small 2007, 3, 290-293.
19. Lee, Y. A.; Kim, Y. J.; Cho, E. J.; Yokozawa, T. Ameliorative effects of proanthocyanidin on oxidative stress and inflammation in streptozotocin-induced diabetic rats. J. Agrie. Food. Chem. 2007, 55, 9395-9400.
20. Taylor, M. D. Causation of diabetes type 2-the Gordian knot unravels. N. Engl. J. Med. 2004, 350, 639-641.
21. Hannon-Fletcher, M. P. A.; O'Kane, M. J.; Moles, K. W.; Weatherup, C.; Barnett, C. R.; Barnett, Y. A. Levels of peripheral blood cell DNA damage in insulin dependent diabetes mellitus human subjects. Mutat. Res. 2000, 460, 53-60.
22. Onaran, I.; Guven, G. S.; Ozdas, S. B.; Kanigur, G.; Vehid, S. Metformin does not prevent DNA damage in lymphocytes despite its antioxidant properties against cumene hydroperoxide-induced oxidative stress. Mutat. Res. 2006, 611, 1-8.
23. Muller, F. L.; Lustgarten, M. S.; Jang, Y.; Richardson, A.; Van Remmen, H. Trends in oxidative aging theories. Free Radical Biol. Med. 2007, 43, 477-503.
24. Frankel, E. N.; Finley, J. W. How to standardize the multiplicity of methods to evaluate natural antioxidants. J. Agrie. Food Chem. 2008, 56, 4901-4908.
25. Zhou, G. C.; Myers, R.; Li, Y.; Chen, Y. L.; Shen, X. L.; Fenyk-Melody, J.; Wu, M.; Ventre, J.; Doebber, T.; Fuji, N.; Musi, N.; Hirshman, M. F.; Goodyear, L. J.; Moller, D. E. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 2001, 108, 1167-1174.
26. The Diabetes Control and Complications Trial Research Group (DCTT). Long-term defects of diabetes and its treatment on cognitive function. N. Engl. J. Med. 2007, 356, 1842-1852.
27. Unger, R. H.; Orci, L. Diseases of lipid overflow: new perspective on obesity and related disorders. FASEB J. 2001, 15, 312-321.
28. Zang, M. W.; Xu, S. Q.; Maitland-Toolan, K. A.; Zuccollo, A.; Hou, X. Y.; Jiang, B. B.; Wierzbicki, M.; Verbeuren, T.; Cohen, R. A. Polyphenols atimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 2006, 55, 2180-2191.
29. Bonnevie-Nielsen, V.; Steffes, M. W.; Lernmark, A. A major loss in islet mass and β-cell function precedes hyperglycemia in mice given multiple doses of streptozotocin. Diabetes 1981, 30, 424-429.
30. Garofano, A.; Czernichow, P.; Bréant, B. Impaired β-cell regeneration in perinatally malnourished rats: a study with STZ. FASEB J. 2000, 14, 2611-2617.